New Oral Obesity Drug Shows 12% Weight Loss in Trial

A pill-based weight loss medication achieved up to 12% body weight reduction in clinical trials, offering a more accessible alternative to injectable drugs like Ozempic.

The oral drug could transform obesity treatment by eliminating needles, refrigeration, and high manufacturing costs.